Biological Innovation:Monoclonal antibodies, vaccines, cell therapies, gene therapies, peptide drugs, recombinant proteins, biosimilars, immunotherapies, CRISPR, gene editing, microbiome therapies, regenerative medicine, synthetic biology, exosome therapies, and novel pharmaceuticals

Bio‑Intelligence:Diagnostic devices, therapeutic equipment, monitoring systems, IVDs, molecular diagnostics, pathology diagnostics, medical monitors, POCT, artificial intelligence and big data, digital health, wearable devices, AI‑powered biomedical imaging, telemedicine and remote monitoring, surgical robots, and home‑use medical devices

Bio‑Convergence:Analytical instruments, laboratory consumables, experimental equipment, reagents and supplies, biomaterials, industrial bioproducts, CROs, CMOs, CDMOs, testing services, consulting and training services, bioinformatics services, and measurement instruments

Bio‑Accelerators:Investments in biopharmaceuticals, venture capital, mergers and acquisitions, licensing and partnerships, IPOs and fundraising, government grants and subsidies, industry policies and regulations, market analysis and trends, technology transfer, incubators and accelerators, as well as corporate strategy and development